|
|
Volumn 38, Issue 4, 2001, Pages 307-314
|
|
Sickle cell disease: Current clinical management
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIBIOTIC AGENT;
ANTIDEPRESSANT AGENT;
ANTIHISTAMINIC AGENT;
BUPRENORPHINE;
BUTORPHANOL TARTRATE;
CELECOXIB;
CHOLINE MAGNESIUM TRISALICYLATE;
CODEINE;
DIFLUNISAL;
FENTANYL;
FENTANYL CITRATE;
FOLIC ACID;
HYDROMORPHONE;
IBUPROFEN;
KETOROLAC;
LEVORPHANOL;
MELOXICAM;
METHADONE;
MORPHINE;
MORPHINE SULFATE;
NALBUPHINE;
NAPROXEN;
NARCOTIC ANALGESIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
OXYCODONE;
OXYMORPHONE;
PARACETAMOL;
PENTAZOCINE;
PERCOCET;
PETHIDINE;
ROFECOXIB;
TYLOX;
UNINDEXED DRUG;
CLINICAL FEATURE;
CONSTIPATION;
EDUCATION;
EMPLOYMENT;
FAMILY;
FOLIC ACID DEFICIENCY;
HUMAN;
INFECTION;
INTIMACY;
IRON DEFICIENCY ANEMIA;
MULTIPLE ORGAN FAILURE;
NAUSEA;
PAIN;
PATHOPHYSIOLOGY;
PHENOTYPE;
PRIORITY JOURNAL;
PRURITUS;
RELIGION;
RESPIRATION DEPRESSION;
REVIEW;
SEDATION;
SICKLE CELL ANEMIA;
SOCIAL INTERACTION;
VOMITING;
|
|
EID: 0034782782
PISSN: 00371963
EISSN: None
Source Type: Journal
DOI: 10.1016/S0037-1963(01)90024-1 Document Type: Article |
|
Times cited : (21)
|
|
References (21)
|
